Canada Pension Plan Investment Board
FULC icon

Canada Pension Plan Investment Board’s Fulcrum Therapeutics FULC Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
102,400
+84,000
+457% +$511K ﹤0.01% 1375
2026
Q1 		$141K Buy
+18,400
New +$171K ﹤0.01% 1621

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's FULC Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Fulcrum Therapeutics (FULC) stake by 457% in Q2 2026, buying an estimated $511K and bringing the position to 102,400 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Canada Pension Plan Investment Board first reported a position in FULC in Q1 2026 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Canada Pension Plan Investment Board held 102,400 shares of Fulcrum Therapeutics worth $375K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 84,000 Fulcrum Therapeutics shares in Q2 2026, an estimated $511K.
  • Fulcrum Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1375 holding.
  • Canada Pension Plan Investment Board first reported a position in Fulcrum Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.